Log in to search using one of your social media accounts:

 

Determination of crystalline silica in respirable dust upon occupational exposure for Egyptian workers.

This study aims to investigate occupational exposure to crystalline silica dust at 22 factories in Egypt with different industrial activities like stone cutting, glass making, ceramic, and sand blasting. Dust samples were collected from work sites at the breathing zone using a personal sampling pump and a size-selective cyclone and analyzed using FTIR. The sampling period was 60-120 min. The results show that the exposure at each of the industrial sectors is very much higher than the current national and international limits, and that lead to a great risk of lung cancer and mortality to workers. PMID: 29199263 [PubMed - as supplied by publisher]
Source: Industrial Health - Category: Occupational Health Tags: Ind Health Source Type: research

Related Links:

Conditions:   Stage IIIB Non-Small Cell Lung Cancer AJCC v7;   Stage IV Non-Small Cell Lung Cancer AJCC v7 Interventions:   Drug: 6,8-Bis(benzylthio)octanoic Acid;   Drug: Docetaxel;   Other: Pharmacological Study Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The PD-1, PD-L1, and CTLA-4 inhibitors show promise in lung cancer, but questions about biomarker use and place in therapy need to be resolved.Chinese Clinical Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
A breast cancer diagnosis is no fun. Actually any cancer diagnosis is no fun. We all know that. But maybe because of all the'awareness', it is now more socially acceptable than other forms of cancer. Isn't that just weird? I think so.Meanwhile, a woman in New Zealand was diagnosed with stage IV lung cancer andshe wonders if breast cancer would be better because of the stigma surrounding smoking and lung cancer.I think lung cancer is the only cancer which is regarded as'self inflicted'.  Face it, as normal human beings we associate lung cancer with smoking. But not all smokers get lung cancer and not all lung cancer pa...
Source: Caroline's Breast Cancer Blog - Category: Cancer & Oncology Tags: breast cancer bonds cancer stigma lung cancer support Source Type: blogs
Authors: Toschi L, Rossi S, Finocchiaro G, Santoro A Abstract Diagnostic and treatment algorithms in non-small cell lung cancer (NSCLC) are evolving at a never-before-seen pace. Histological subtyping to maximise treatment efficacy and avoid toxicity has marked the beginning of the revolution, opening the way to molecular characterisation to guide genomically driven treatments with targeted agents, led by Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) inhibitors. More recently, agents against the Program Death 1 receptor (PD-1) and ligand 1 (PD-L1) have entered the clinical arena, offe...
Source: Ecancermedicalscience - Category: Cancer & Oncology Tags: Ecancermedicalscience Source Type: research
Authors: Vavalà T Abstract Lung cancer treatment has considerably changed over the last few years: the identification of druggable oncogenic alterations and innovative immunotherapic approaches granted lung cancer patients the possibility of more efficient and less toxic therapeutic options than chemotherapy. Nowadays, lung squamous cell carcinomas (SqCCs) patients have the chance to benefit from novel treatment alternatives, including immune checkpoint blockade and anti-angiogenic agents and, given positive trial results, from afatinib, a second generation tyrosine kinase inhibitor (TKI) that irreversibly a...
Source: Clinical Pharmacology: Advances and Applications - Category: Allergy & Immunology Tags: Clin Pharmacol Source Type: research
LUNG CANCER symptoms include a long-standing cough, and feeling low on energy. These are other signs to watch out for.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Authors: Kann BH, Park HS, Johnson SB, Chiang VL, Yu JB Abstract Background: Management of brain metastases typically includes radiotherapy (RT) with conventional fractionation and/or stereotactic radiosurgery (SRS). However, optimal indications and practice patterns for SRS remain unclear. We sought to evaluate national practice patterns for patients with metastatic disease receiving brain RT. Methods: We queried the National Cancer Data Base (NCDB) for patients diagnosed with metastatic non-small cell lung cancer, breast cancer, colorectal cancer, or melanoma from 2004 to 2014 who received upfront brain RT. Patie...
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research
The erudite letter from the ASTRO Evidence-Based Guideline Committee for Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non –Small Cell Lung Cancer (ASTRO Group)1 carries a title that all clinicians managing lung cancer could easily agree on. Conversely, the style of the letter is typical of a diplomatic effort that may not to stand the test of time because of the underlying biases of both radiation oncologists and tho racic surgeons.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Thoracic: Lung cancer: Letter to the editor Source Type: research
In their original article, Smeltzer and colleagues1 used the National Cancer Database to validate our current National Comprehensive Cancer Network guidelines on adjuvant modalities for incompletely resected non –small cell lung cancer (NSCLC). In contrast to what might be expected from these current guidelines, Smeltzer and colleagues1 demonstrated that postoperative radiotherapy was associated with a significantly worse survival outcome for patients with incompletely resected early-stage NSCLC than for those not treated.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Thoracic: Lung cancer: Letter to the editor Source Type: research
In the closing remarks of an editorial recently published in the Journal, Schaheen and D'Cunha1 highlight the challenge for thoracic surgeons to adequately compare the efficacy of surgical resection and stereotactic body radiation  therapy (SBRT) for patients with operable stage I non–small cell lung cancer (NSCLC).1 We agree with their comments that “our patients aren't fully able to dissect the literature and the nuances of the trials”1 that have been published in the peer-reviewed literature and then recycled in the lay media with sensationalized headlines.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Thoracic: Lung cancer: Letter to the editor Source Type: research
More News: Cancer | Cancer & Oncology | Egypt Health | Government | Lung Cancer | Occupational Health | Study